The comparison of the efficacy and safety between Temziva and Actemra in treatment of the patient with active Rheumatoid Arthritis

计划入组 272 人

An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study

计划入组 95 人 · 首次发布于 2012 年 4 月 30 日

An Open-Label Extension Study to Evaluate Long-Term Safety and Tolerability of RO7234292 (RG6042) in Huntington's Disease Participants Who Participated in Prior Roche and Genentech Sponsored Studies

计划入组 236 人 · 首次发布于 2019 年 2 月 15 日

Anti-NaPi3b antibody-drug conjugate(Genentech/Roche)

tyrosine phosphatase inhibitors (Roche)

Myxopyronins (Roche)

Genentech

United States

GENENTECH INC

United States

GENENTECH, INC.

United States

Genentech and Roche Secure UPC Evidence Orders Against Organon's Pertuzumab Biosimilar

Roche Launches Innovation Center at Harvard's Enterprise Research Campus to Advance CVRM Research and AI Applications

Genentech's Phase IIb Study of Prasinezumab in Early-Stage Parkinson's Disease Misses Primary Goal